Shaofeng Chen , Weide Xiong , Xiaoyu Lin , Xuejun Wu , Chuanyi Yao , Yinghua Lu , Xueping Ling
{"title":"Improved performance of toxic Streptomyces phospholipase D expression by combinatorial optimization in the trehalase-deficient Escherichia coli","authors":"Shaofeng Chen , Weide Xiong , Xiaoyu Lin , Xuejun Wu , Chuanyi Yao , Yinghua Lu , Xueping Ling","doi":"10.1016/j.bej.2025.109640","DOIUrl":null,"url":null,"abstract":"<div><div>Phospholipase D (PLD) has a unique phosphatidyl catalytic site and is capable of synthesizing a variety of active phospholipids, such as phosphatidylserine, for use in the food industry. However, the microbial production of PLD is limited by its cytotoxicity. In this study, the constructed trehalase-deficient strains by CRISPR-Cas9 showed increased intracellular trehalose content and high performance in PLD production. Molecular dynamics (MD) simulations suggested that trehalose could stabilize the natural conformation of PLD, increase its solubility and expression. High PLD production (47.63 U/mL) was achieved in the recombinant strain <em>E. coli</em> BW25113 <em>ΔtreA ΔtreC ΔtreF</em> using an optimized culture strategy, with an efficiency of 5.95 U/mL/h—the highest level reported in shake flask cultures to date. Our results showed that the accumulated endogenous trehalose improved the salt tolerance of cells to alleviate PLD cytotoxicity and promote continuous PLD expression. Thus, the trehalase-deficient <em>Escherichia coli</em> expression system shows great potential for application in industrial PLD production.</div></div>","PeriodicalId":8766,"journal":{"name":"Biochemical Engineering Journal","volume":"215 ","pages":"Article 109640"},"PeriodicalIF":3.7000,"publicationDate":"2025-01-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biochemical Engineering Journal","FirstCategoryId":"5","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1369703X25000130","RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Phospholipase D (PLD) has a unique phosphatidyl catalytic site and is capable of synthesizing a variety of active phospholipids, such as phosphatidylserine, for use in the food industry. However, the microbial production of PLD is limited by its cytotoxicity. In this study, the constructed trehalase-deficient strains by CRISPR-Cas9 showed increased intracellular trehalose content and high performance in PLD production. Molecular dynamics (MD) simulations suggested that trehalose could stabilize the natural conformation of PLD, increase its solubility and expression. High PLD production (47.63 U/mL) was achieved in the recombinant strain E. coli BW25113 ΔtreA ΔtreC ΔtreF using an optimized culture strategy, with an efficiency of 5.95 U/mL/h—the highest level reported in shake flask cultures to date. Our results showed that the accumulated endogenous trehalose improved the salt tolerance of cells to alleviate PLD cytotoxicity and promote continuous PLD expression. Thus, the trehalase-deficient Escherichia coli expression system shows great potential for application in industrial PLD production.
期刊介绍:
The Biochemical Engineering Journal aims to promote progress in the crucial chemical engineering aspects of the development of biological processes associated with everything from raw materials preparation to product recovery relevant to industries as diverse as medical/healthcare, industrial biotechnology, and environmental biotechnology.
The Journal welcomes full length original research papers, short communications, and review papers* in the following research fields:
Biocatalysis (enzyme or microbial) and biotransformations, including immobilized biocatalyst preparation and kinetics
Biosensors and Biodevices including biofabrication and novel fuel cell development
Bioseparations including scale-up and protein refolding/renaturation
Environmental Bioengineering including bioconversion, bioremediation, and microbial fuel cells
Bioreactor Systems including characterization, optimization and scale-up
Bioresources and Biorefinery Engineering including biomass conversion, biofuels, bioenergy, and optimization
Industrial Biotechnology including specialty chemicals, platform chemicals and neutraceuticals
Biomaterials and Tissue Engineering including bioartificial organs, cell encapsulation, and controlled release
Cell Culture Engineering (plant, animal or insect cells) including viral vectors, monoclonal antibodies, recombinant proteins, vaccines, and secondary metabolites
Cell Therapies and Stem Cells including pluripotent, mesenchymal and hematopoietic stem cells; immunotherapies; tissue-specific differentiation; and cryopreservation
Metabolic Engineering, Systems and Synthetic Biology including OMICS, bioinformatics, in silico biology, and metabolic flux analysis
Protein Engineering including enzyme engineering and directed evolution.